Importantly our data suggest that inhibiting Caspase-1 with VX765 has the most potent anti-cancer effects, inhibiting bone metastasis whilst having the least detrimental effect on systemic immunity, suggesting that this drug may be the best option for future development. This evidence concerns the gene CASP1 and cancer.